Stereotactic body radiation therapy (SBRT) for the treatment of primary lung cancer in recipients of lung transplant

Lung transplantation is a life-saving treatment for patients with end stage lung disease. There may be a higher incidence of lung cancer in lung transplant recipients, and these cancers tend to be diagnosed at a more advanced stage. There is very little data on the safety and efficacy of stereotacti...

Full description

Bibliographic Details
Main Authors:	Moore Assaf, Kramer Mordechai R., Rosengarten Dror, Shtraichman Osnat, Zer Alona, Dudnik Elizabeth, Korzets Yasmin, Allen Aaron M.
Format:	Article
Language:	English
Published:	Sciendo 2020-04-01
Series:	Radiology and Oncology
Subjects:	stereotactic body radiation therapy (sbrt) lung transplantation lung cancer radiotherapy
Online Access:	https://doi.org/10.2478/raon-2020-0022

id	doaj-c9c10c95143242448829816e06877a19
record_format	Article
spelling	doaj-c9c10c95143242448829816e06877a192021-09-05T14:01:19ZengSciendoRadiology and Oncology1581-32072020-04-0154222723210.2478/raon-2020-0022raon-2020-0022Stereotactic body radiation therapy (SBRT) for the treatment of primary lung cancer in recipients of lung transplantMoore Assaf0Kramer Mordechai R.1Rosengarten Dror2Shtraichman Osnat3Zer Alona4Dudnik Elizabeth5Korzets Yasmin6Allen Aaron M.7Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petach Tiqva, IsraelThe Institute of Pulmonary Medicine, Rabin Medical Center, Petach Tiqva, IsraelThe Institute of Pulmonary Medicine, Rabin Medical Center, Petach Tiqva, IsraelThe Institute of Pulmonary Medicine, Rabin Medical Center, Petach Tiqva, IsraelInstitute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petach Tiqva, IsraelInstitute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petach Tiqva, IsraelInstitute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petach Tiqva, IsraelInstitute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petach Tiqva, IsraelLung transplantation is a life-saving treatment for patients with end stage lung disease. There may be a higher incidence of lung cancer in lung transplant recipients, and these cancers tend to be diagnosed at a more advanced stage. There is very little data on the safety and efficacy of stereotactic body radiation therapy (SBRT) for lesions in the native lung in lung-transplant recipients.https://doi.org/10.2478/raon-2020-0022stereotactic body radiation therapy (sbrt)lung transplantationlung cancerradiotherapy
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Moore Assaf Kramer Mordechai R. Rosengarten Dror Shtraichman Osnat Zer Alona Dudnik Elizabeth Korzets Yasmin Allen Aaron M.
spellingShingle	Moore Assaf Kramer Mordechai R. Rosengarten Dror Shtraichman Osnat Zer Alona Dudnik Elizabeth Korzets Yasmin Allen Aaron M. Stereotactic body radiation therapy (SBRT) for the treatment of primary lung cancer in recipients of lung transplant Radiology and Oncology stereotactic body radiation therapy (sbrt) lung transplantation lung cancer radiotherapy
author_facet	Moore Assaf Kramer Mordechai R. Rosengarten Dror Shtraichman Osnat Zer Alona Dudnik Elizabeth Korzets Yasmin Allen Aaron M.
author_sort	Moore Assaf
title	Stereotactic body radiation therapy (SBRT) for the treatment of primary lung cancer in recipients of lung transplant
title_short	Stereotactic body radiation therapy (SBRT) for the treatment of primary lung cancer in recipients of lung transplant
title_full	Stereotactic body radiation therapy (SBRT) for the treatment of primary lung cancer in recipients of lung transplant
title_fullStr	Stereotactic body radiation therapy (SBRT) for the treatment of primary lung cancer in recipients of lung transplant
title_full_unstemmed	Stereotactic body radiation therapy (SBRT) for the treatment of primary lung cancer in recipients of lung transplant
title_sort	stereotactic body radiation therapy (sbrt) for the treatment of primary lung cancer in recipients of lung transplant
publisher	Sciendo
series	Radiology and Oncology
issn	1581-3207
publishDate	2020-04-01
description	Lung transplantation is a life-saving treatment for patients with end stage lung disease. There may be a higher incidence of lung cancer in lung transplant recipients, and these cancers tend to be diagnosed at a more advanced stage. There is very little data on the safety and efficacy of stereotactic body radiation therapy (SBRT) for lesions in the native lung in lung-transplant recipients.
topic	stereotactic body radiation therapy (sbrt) lung transplantation lung cancer radiotherapy
url	https://doi.org/10.2478/raon-2020-0022
work_keys_str_mv	AT mooreassaf stereotacticbodyradiationtherapysbrtforthetreatmentofprimarylungcancerinrecipientsoflungtransplant AT kramermordechair stereotacticbodyradiationtherapysbrtforthetreatmentofprimarylungcancerinrecipientsoflungtransplant AT rosengartendror stereotacticbodyradiationtherapysbrtforthetreatmentofprimarylungcancerinrecipientsoflungtransplant AT shtraichmanosnat stereotacticbodyradiationtherapysbrtforthetreatmentofprimarylungcancerinrecipientsoflungtransplant AT zeralona stereotacticbodyradiationtherapysbrtforthetreatmentofprimarylungcancerinrecipientsoflungtransplant AT dudnikelizabeth stereotacticbodyradiationtherapysbrtforthetreatmentofprimarylungcancerinrecipientsoflungtransplant AT korzetsyasmin stereotacticbodyradiationtherapysbrtforthetreatmentofprimarylungcancerinrecipientsoflungtransplant AT allenaaronm stereotacticbodyradiationtherapysbrtforthetreatmentofprimarylungcancerinrecipientsoflungtransplant
_version_	1717810372864376832

Stereotactic body radiation therapy (SBRT) for the treatment of primary lung cancer in recipients of lung transplant

Similar Items